Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
5.22
+0.15 (2.96%)
At close: Nov 5, 2024, 4:00 PM
5.15
-0.07 (-1.36%)
After-hours: Nov 5, 2024, 4:58 PM EST
Humacyte Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Humacyte stock have an average target of 11.5, with a low estimate of 3.00 and a high estimate of 25. The average target predicts an increase of 120.31% from the current stock price of 5.22.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Humacyte stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 4 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $12 | Strong Buy | Maintains | $6 → $12 | +129.89% | Nov 5, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +378.93% | Oct 28, 2024 |
| TD Cowen | TD Cowen | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +91.57% | Oct 18, 2024 |
| BTIG | BTIG | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +91.57% | Oct 18, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +187.36% | Oct 10, 2024 |
Financial Forecast
Revenue This Year
357.00K
Revenue Next Year
16.84M
from 357.00K
Increased by 4,615.69%
EPS This Year
-1.23
from -1.07
EPS Next Year
-0.87
from -1.23
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.6M | 42.1M | 308.0M | ||
| Avg | 357,000 | 16.8M | 129.8M | ||
| Low | n/a | 6.7M | 58.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 11,694.1% | 1,729.2% | ||
| Avg | - | 4,615.7% | 671.2% | ||
| Low | - | 1,766.7% | 249.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.04 | -0.70 | 1.25 | ||
| Avg | -1.23 | -0.87 | -0.18 | ||
| Low | -1.26 | -1.06 | -0.57 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.